Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz

Almost 80 to 90% of cancer cells show a high telomerase activity compared to normal, differentiated cells. Telomerase activity in cancer cells depend on several factors: increased hTERT expression, modification of telomerase structural subunits and telomere associated proteins. In contrast to other...

Full description

Bibliographic Details
Main Author:	A.Aziz, Noorfaiza
Format:	Thesis
Language:	English
Published:	2016
Online Access:	http://ir.uitm.edu.my/id/eprint/18627/ http://ir.uitm.edu.my/id/eprint/18627/1/TM_NOORFAIZA%20A.AZIZ%20MD%2016_5.pdf

id	uitm-18627
recordtype	eprints
spelling	uitm-186272018-01-10T03:41:04Z http://ir.uitm.edu.my/id/eprint/18627/ Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz A.Aziz, Noorfaiza Almost 80 to 90% of cancer cells show a high telomerase activity compared to normal, differentiated cells. Telomerase activity in cancer cells depend on several factors: increased hTERT expression, modification of telomerase structural subunits and telomere associated proteins. In contrast to other breast cancer types, treatment options for Triple Negative Breast Cancer (TNBC) are limited due to a lack of specific molecular targets. Therefore, in this study the effect of apigenin, cisplatin and the combination of both on telomerase activity and structure was investigated in two different types of TNBC (MDA-MB-231 and HCC1806) and one control cell line (MCF10A). The transcriptional and translational expression of telomerase subunits namely Human telomerase reverse transcriptase (hTERT), Heat Shocked Protein 90 (Hsp90), Human Prostaglandin E synthase 3 (p23) as well as telomere-associated proteins; Telomeric Repeat Binding Factor-1 (TRF1), Telomeric Repeat Binding Factor-2 (TRF2), Protection of Telomere 1 (TIN2), TRF1 Interacting Protein 2 (POT1), POT1 and TIN2- Organizing Protein (TPP1) and Transcriptional Repressor/Activator Protein (RAP1) were measured using quantitative Real Time Polymerase Chain Reaction (qRT-PCR) and Enzyme-linked Immunosorbent Assay (ELISA). Apigenin with cisplatin showed synergistic effects with regards to increasing apoptosis and reducing telomerase activity in TNBC cells. However, the combined treatment did not show any protective effect on MCF10A cells. Reduction of telomerase activity by the combined treatment was associated with the reduction of Hsp90 and p23 expression in TNBC cells. The decrease of the shelterin subunits, POT1 and TPP1 after combined treatment also seem to be involved in regulating telomerase activity in TNBC cells. However, the deactivation of telomerase by the combination is strongly dependent on the subtype of TNBC used. In conclusion telomerase activity and shelterin components area potential target for the treatment of TNBC. However, further studies are required to investigate the effect of combined treatment in the non-tumour tissue. To date, this is the first study that demonstrated the synergistic effect of apigenin with cisplatin on TNBC cells. 2016 Thesis NonPeerReviewed text en http://ir.uitm.edu.my/id/eprint/18627/1/TM_NOORFAIZA%20A.AZIZ%20MD%2016_5.pdf A.Aziz, Noorfaiza (2016) Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz. Masters thesis, Universiti Teknologi MARA.
repository_type	Digital Repository
institution_category	Local University
institution	Universiti Teknologi MARA
building	UiTM Institutional Repository
collection	Online Access
language	English
description	Almost 80 to 90% of cancer cells show a high telomerase activity compared to normal, differentiated cells. Telomerase activity in cancer cells depend on several factors: increased hTERT expression, modification of telomerase structural subunits and telomere associated proteins. In contrast to other breast cancer types, treatment options for Triple Negative Breast Cancer (TNBC) are limited due to a lack of specific molecular targets. Therefore, in this study the effect of apigenin, cisplatin and the combination of both on telomerase activity and structure was investigated in two different types of TNBC (MDA-MB-231 and HCC1806) and one control cell line (MCF10A). The transcriptional and translational expression of telomerase subunits namely Human telomerase reverse transcriptase (hTERT), Heat Shocked Protein 90 (Hsp90), Human Prostaglandin E synthase 3 (p23) as well as telomere-associated proteins; Telomeric Repeat Binding Factor-1 (TRF1), Telomeric Repeat Binding Factor-2 (TRF2), Protection of Telomere 1 (TIN2), TRF1 Interacting Protein 2 (POT1), POT1 and TIN2- Organizing Protein (TPP1) and Transcriptional Repressor/Activator Protein (RAP1) were measured using quantitative Real Time Polymerase Chain Reaction (qRT-PCR) and Enzyme-linked Immunosorbent Assay (ELISA). Apigenin with cisplatin showed synergistic effects with regards to increasing apoptosis and reducing telomerase activity in TNBC cells. However, the combined treatment did not show any protective effect on MCF10A cells. Reduction of telomerase activity by the combined treatment was associated with the reduction of Hsp90 and p23 expression in TNBC cells. The decrease of the shelterin subunits, POT1 and TPP1 after combined treatment also seem to be involved in regulating telomerase activity in TNBC cells. However, the deactivation of telomerase by the combination is strongly dependent on the subtype of TNBC used. In conclusion telomerase activity and shelterin components area potential target for the treatment of TNBC. However, further studies are required to investigate the effect of combined treatment in the non-tumour tissue. To date, this is the first study that demonstrated the synergistic effect of apigenin with cisplatin on TNBC cells.
format	Thesis
author	A.Aziz, Noorfaiza
spellingShingle	A.Aziz, Noorfaiza Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz
author_facet	A.Aziz, Noorfaiza
author_sort	A.Aziz, Noorfaiza
title	Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz
title_short	Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz
title_full	Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz
title_fullStr	Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz
title_full_unstemmed	Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz
title_sort	effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / noorfaiza a.aziz
publishDate	2016
url	http://ir.uitm.edu.my/id/eprint/18627/ http://ir.uitm.edu.my/id/eprint/18627/1/TM_NOORFAIZA%20A.AZIZ%20MD%2016_5.pdf
first_indexed	2023-09-18T23:00:57Z
last_indexed	2023-09-18T23:00:57Z
_version_	1777418169527304192

Effect of apigenin and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer / Noorfaiza A.Aziz

Similar Items